Lobular Carcinoma in Situ of the Breast
- 1 January 2018
- book chapter
- Published by Elsevier
- p. 553-561.e2
- https://doi.org/10.1016/b978-0-323-35955-9.00038-6
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Trends in Incidence and Management of Lobular Carcinoma In Situ: A Population-Based AnalysisAnnals of Surgical Oncology, 2013
- Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsyLaboratory Investigation, 2013
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk ReductionJournal of Clinical Oncology, 2009
- Factors predicting in-breast tumor recurrence after breast-conserving surgeryBreast Cancer Research and Treatment, 2008
- Presence of Lobular Carcinoma In Situ Does Not Increase Local Recurrence in Patients Treated with Breast-Conserving TherapyAnnals of Surgical Oncology, 2008
- The significance of lobular neoplasia on needle core biopsy of the breastVirchows Archiv, 2008
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialThe Lancet Oncology, 2008
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic ImplicationsAmerican Journal of Clinical Pathology, 2001
- Persistent and atypical lobules in the human breast may be precancerousCellular and Molecular Life Sciences, 1976